Skip to main content

Table 4 Summary of outcomes for peripheral brain and blood GSH by qualitative assessment. Studies with 10 or more items rated as “yes” in the qualitative risk of bias assessment were categorized as likely to be “low risk of bias”

From: Altered central and blood glutathione in Alzheimer’s disease and mild cognitive impairment: a meta-analysis

Studies and sub-studies (n)

SMD [95% CI]

z

p

X2

I2 (%)

p

Brain GSH

AD (all)

(7)

0.07 [-1.29, 1.43]

0.1

0.92

173.46

96.5

<0.001

AD (low risk of bias)

(4)

0.59 [-2.04, 3.23]

0.44

0.66

141.01

97.9

<0.001

MCI (all)

(8)

-0.43 [-1.19, 0.33]

1.12

0.26

92.32

92.4

<0.001

MCI (low risk of bias)

(6)

-0.19 [-1.04, 0.67]

0.43

0.67

64.08

92.2

<0.001

Blood GSH

AD (all)

(31)

-1.18 [-1.65, -0.71]

4.9

<0.001

728.87

95.9

<0.001

AD (low risk of bias)

(17)

-0.87 [-1.56, -0.20]

2.53

0.01

447.49

96.4

<0.001

MCI (all)

(8)

-0.70 [-1.84, 0.44]

1.21

0.23

322.88

97.8

<0.001

MCI (low risk of bias)

(6)

-0.65 [-2.13, 0.84]

0.85

0.39

315.61

98.4

<0.001